<\/p>\n\n
Understanding how a tumor evolves over time to anticipate its moves and neutralize it before it can strike the patient again. This is the core focus of the 37th Pezcoller Symposium, hosted yesterday and today by the University of Trento, which brought together over 240 scientists, physicians, and researchers from every corner of the globe. <\/p>\n\n
<\/p>\n\n
As explained by Enzo Galligioni, President of the Pezcoller Foundation, this year’s Symposium focuses on the study of cancer\u2019s evolutionary pathways<\/strong> in an effort to understand\u2014and anticipate\u2014its mutations and subsequent drug resistance. This challenge represents perhaps one of the most critical priorities on the global healthcare agenda, given the staggering number of cancer diagnoses, a disease that claims over 190,000 lives each year in Italy alone. <\/p>\n\n <\/p>\n\n <\/p>\n\n <\/p>\n\n <\/p>\n\n <\/p>\n\n